Unknown

Dataset Information

0

SARS-CoV-2 3C-like protease antagonizes interferon-beta production by facilitating the degradation of IRF3.

ABSTRACT: The prevalence of SARS-CoV-2 is a great threat to global public health. However, the relationship between the viral pathogen SARS-CoV-2 and host innate immunity has not yet been well studied. The genome of SARS-CoV-2 encodes a viral protease called 3C-like protease. This protease is responsible for cleaving viral polyproteins during replication. In this investigation, 293T cells were transfected with SARS-CoV-2 3CL and then infected with Sendai virus (SeV) to induce the RIG-I like receptor (RLR)-based immune pathway. q-PCR, luciferase reporter assays, and western blotting were used for experimental analyses. We found that SARS-CoV-2 3CL significantly downregulated IFN-β mRNA levels. Upon SeV infection, SARS-CoV-2 3CL inhibited the nuclear translocation of IRF3 and p65 and promoted the degradation of IRF3. This effect of SARS-CoV-2 3CL on type I IFN in the RLR immune pathway opens up novel ideas for future research on SARS-CoV-2.

SUBMITTER: Zhang W 

PROVIDER: S-EPMC8413301 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

SARS-CoV-2 3C-like protease antagonizes interferon-beta production by facilitating the degradation of IRF3.

Zhang Wenwen W   Ma Zhenling Z   Wu Yaru Y   Shi Xixi X   Zhang Yanyan Y   Zhang Min M   Zhang Menghao M   Wang Lei L   Liu Wei W  

Cytokine 20210903

The prevalence of SARS-CoV-2 is a great threat to global public health. However, the relationship between the viral pathogen SARS-CoV-2 and host innate immunity has not yet been well studied. The genome of SARS-CoV-2 encodes a viral protease called 3C-like protease. This protease is responsible for cleaving viral polyproteins during replication. In this investigation, 293T cells were transfected with SARS-CoV-2 3CL and then infected with Sendai virus (SeV) to induce the RIG-I like receptor (RLR)  ...[more]

Similar Datasets

Unknown SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation.
| S-EPMC7907794 | biostudies-literature
Unknown Porcine Epidemic Diarrhea Virus nsp15 Antagonizes Interferon Signaling by RNA Degradation of TBK1 and IRF3.
| S-EPMC7354440 | biostudies-literature
Unknown SARS-CoV-2 Nsp15 suppresses type I interferon production by inhibiting IRF3 phosphorylation and nuclear translocation.
| S-EPMC10480782 | biostudies-literature
Unknown Interferon regulatory factor 3-CL, an isoform of IRF3, antagonizes activity of IRF3.
| S-EPMC4002990 | biostudies-literature
Unknown Foot-and-Mouth Disease Virus 3C Protease Antagonizes Interferon Signaling and C142T Substitution Attenuates the FMD Virus.
| S-EPMC8639872 | biostudies-literature
Unknown Crystal structure of SARS-CoV 3C-like protease with baicalein.
| S-EPMC9027212 | biostudies-literature
Unknown Production of a functionally active recombinant SARS-CoV-2 (COVID-19) 3C-like protease and a soluble inactive 3C-like protease-RBD chimeric in a prokaryotic expression system.
| S-EPMC9300977 | biostudies-literature
Unknown Progress in Developing Inhibitors of SARS-CoV-2 3C-Like Protease.
| S-EPMC7463875 | biostudies-literature
Unknown Oridonin Inhibits SARS-CoV-2 by Targeting Its 3C-Like Protease.
| S-EPMC9111243 | biostudies-literature
Unknown African swine fever virus S273R protein antagonizes type I interferon production by interfering with TBK1 and IRF3 interaction.
| S-EPMC10786655 | biostudies-literature